1. Home
  2. IDYA vs PATK Comparison

IDYA vs PATK Comparison

Compare IDYA & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • PATK
  • Stock Information
  • Founded
  • IDYA 2015
  • PATK 1959
  • Country
  • IDYA United States
  • PATK United States
  • Employees
  • IDYA N/A
  • PATK N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • PATK Auto Parts:O.E.M.
  • Sector
  • IDYA Health Care
  • PATK Consumer Discretionary
  • Exchange
  • IDYA Nasdaq
  • PATK Nasdaq
  • Market Cap
  • IDYA 2.6B
  • PATK 3.0B
  • IPO Year
  • IDYA 2019
  • PATK N/A
  • Fundamental
  • Price
  • IDYA $26.64
  • PATK $128.50
  • Analyst Decision
  • IDYA Strong Buy
  • PATK Strong Buy
  • Analyst Count
  • IDYA 12
  • PATK 8
  • Target Price
  • IDYA $53.08
  • PATK $139.88
  • AVG Volume (30 Days)
  • IDYA 750.9K
  • PATK 304.8K
  • Earning Date
  • IDYA 11-04-2024
  • PATK 10-31-2024
  • Dividend Yield
  • IDYA N/A
  • PATK 1.71%
  • EPS Growth
  • IDYA N/A
  • PATK 2.83
  • EPS
  • IDYA N/A
  • PATK 6.96
  • Revenue
  • IDYA $3,922,000.00
  • PATK $3,650,747,000.00
  • Revenue This Year
  • IDYA N/A
  • PATK $8.82
  • Revenue Next Year
  • IDYA $158.10
  • PATK $7.42
  • P/E Ratio
  • IDYA N/A
  • PATK $18.46
  • Revenue Growth
  • IDYA N/A
  • PATK 0.33
  • 52 Week Low
  • IDYA $26.41
  • PATK $80.62
  • 52 Week High
  • IDYA $47.74
  • PATK $148.35
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 33.96
  • PATK 45.94
  • Support Level
  • IDYA $27.52
  • PATK $126.91
  • Resistance Level
  • IDYA $32.67
  • PATK $134.29
  • Average True Range (ATR)
  • IDYA 1.44
  • PATK 5.37
  • MACD
  • IDYA -0.04
  • PATK 0.60
  • Stochastic Oscillator
  • IDYA 3.75
  • PATK 59.72

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: